Pawan Narendrakumar Rajput

Pawan Narendrakumar Rajput

Director Additional Director DIN 08104281
DIN 08104281 First appointment Apr 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Apr 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Pawan Narendrakumar Rajput

Data last updated:

Pawan Narendrakumar Rajput was an Additional Director at Kyro Pharmaceuticals Private Limited (2018). The company operates in Chemicals.

DIN 08104281
Primary Designation Additional Director
Industry Chemicals
First Appointment 06 Apr 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kyro Pharmaceuticals Private Limited U24100MH2010PTC206265
Additional Director06 Apr 20182010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kyro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Narendrakumar Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Narendrakumar Rajput

Pawan Narendrakumar Rajput was first appointed on 06 Apr 2018 as Additional Director at Kyro Pharmaceuticals Private Limited.

Pawan Narendrakumar Rajput held 1 earlier board appointment: Kyro Pharmaceuticals Private Limited (Additional Director, 06 Apr 2018 to 27 Sep 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available